معرفی
Ridvan Nepravishta serves as an Honorary Lecturer in the School of Molecular Biosciences and Affiliate of Beatson Associates in the School of Cancer Sciences at the University of Glasgow, conducting research at the CRUK Scotland Institute (formerly CRUK Beatson Institute). His work bridges cancer biology and structural biochemistry through advanced NMR methodologies.
His research program centers on protein-ligand interactions and cancer target validation, with dual emphases on:
- Methodological innovation in NMR spectroscopy (rd-STD, DEEP-STD, SDTD) for characterizing weak biomolecular complexes
- Translational cancer research focusing on Ras inhibitors, thymosin α1 immunomodulation, and bacterial metabolism pathways relevant to oncology
Analysis of his 15 most recent publications (2020-2025) reveals three dominant research trajectories: 1) Ras protein inhibition strategies spanning conformational state-specific targeting, 2) NMR method development for weak binding validation, and 3) structural characterization of immune modulators like thymosin α1. His work consistently integrates biophysical techniques with cancer biology to address drug discovery challenges.
While no formal advising roles or specific grants are documented in available materials, his extensive collaboration with the CRUK Scotland Institute indicates active participation in cancer research consortia. His laboratory work focuses on NMR-based structural analysis of protein complexes relevant to oncology and infectious disease.
